Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities

Different from surgery, chemical therapy, radio-therapy and target therapy, Chimeric antigen receptor-modified T (CAR-T) cells, a novel adoptive immunotherapy strategy, have been used successfully against both hematological tumors and solid tumors. Although several problems have reduced engineered C...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Long, Chen, Fukun, Niu, Huatao, Li, Jindan, Pu, Yongzhu, Yang, Conghui, Wang, Yue, Huang, Rong, Li, Ke, Lei, Yujie, Huang, Yunchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334018/
https://www.ncbi.nlm.nih.gov/pubmed/35911706
http://dx.doi.org/10.3389/fimmu.2022.871661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334018/
https://www.ncbi.nlm.nih.gov/pubmed/35911706
http://dx.doi.org/10.3389/fimmu.2022.871661

Ejemplares similares